Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Mental Disorders

• ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
• ACP-204 in Adults With Alzheimer's Disease Psychosis
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
• Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
• Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease
• HNC: Human Neural Circuits Electrophysiology During Cognition
• Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder
• Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine
• Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
• Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis
• Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis
• A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
• A Randomized Controlled Trial With Rituximab - for Schizophrenia Spectrum Disorder in Adults
• Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease
• Comparing Antipsychotic Medications in LBD Over Time
• Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY).
• Ketamine and Stress in OCD
• Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
• Defining Neurobiological Links Between Substance Use and Mental Illness
• A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
• An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
• MIBG in Aging and Neurologic Disorders
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease Dementia
• A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
• The Effects of Oxytocin Administration to Patients and Therapists on Physiological Synchronization
• A Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychiatric Disorders
• Pramipexole for Anhedonic Depression
• A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
• Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
• Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
• Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers
• Study to Assess the Efficacy of XPro™ in Patients With Mild Alzheimer's Disease With Biomarkers of Inflammation
• Effects Zulresso on Postpartum Psychosis
• Examining the Effects of Estradiol on Neural and Molecular Response to Reward
• A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder
• The CANabidiol Use for RElief of Short Term Insomnia
• A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression
• Ayurveda Based Intervention for Patients in Acute Psychiatric Crisis Situations
• Terazosin and Parkinson's Disease Extension Study
• Mind to Quit Multisite Trial
• Dopaminergic Therapy for Frontotemporal Dementia Patients
• Relative Bioavailability of LY03010 Compared to Listed Drug
• Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
• Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
• Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
• Add-on MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis
• Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
• Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS Study
• A Study of CST-103 Co-administered With CST-107 in Subjects With Neurodegenerative Disorders
• Adjunctive Celecoxib in Childhood-onset OCD Study
• Pharmacological Modulation of Hippocampal Activity in Psychosis 2
• Prospecta in the Treatment of Cognitive, Behavioural and Psychiatric Disorders in Patients With Vascular Dementia.
• Psychotherapy for Psychosis, Adverse Events, and Substance Misuse
• A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
• Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
• Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
• FAAH Availability in Psychiatric Disorders: A PET Study
• Terazosin Effect on Cardiac Changes in Early Parkinson's Disease
• Pimavanserin vs. Quetiapine for the Treatment Parkinson's Psychosis
• Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)
• Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement
• R33: Levetiracetam in Early Psychosis
• Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
• Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
• Pharmacologic Modulation of Hippocampal Activity in Psychosis
• Effectiveness of a Psychoeducation Program in Patients With Severe Mental Disorder
• Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
• Cardiac Changes in Early Parkinson's Disease: A Follow up Study
• Neuroimmune Dysfunction in Alcohol Use Disorder
• Citalopram and Self Emotional Processing
• Citalopram and Stress Reactivity
• A Study of Efficacy and Safety of Idebenone vs. Placebo in Prodromal Parkinson Disease
• Cannabidiol for Treatment of Recent-onset Psychosis With Comorbid Cannabis Use
• Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness
• Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
• Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
• A Rater-blinded RCT to Compare Effectiveness of EMDR vs TAU in Patients With First Episode Psychosis and History of Psychological Trauma
• Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)
• Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial
• VIP Smoking Cessation Intervention for Adults With Serious Mental Illness
• Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
• Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)
• Clinical Utility of Pharmacogenomics of Psychotropic Medications
• Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
• Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
• Effects of Acute Prucalopride Administration in Healthy Volunteers
• Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder
• Comparison of Drugs on Headache Treatment After ECT Treatment
• Treating Smokers With Mental Illness
• Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
• The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders
• Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease
• The Efficacy of a Herbal Supplement in the Prevention of PTSD
• Exogenous Melatonin in Intensive Care Unit Chronodisruption
• Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls
• SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
• Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection
• Effects of Seven Day Prucalopride Administration in Healthy Volunteers
• A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
• Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness
• So-Lo-Mo Intervention Applied to the Smoking Cessation Process
• Substance Misuse To Psychosis for Stimulants
• Substance Misuse To Psychiatric Disorders for Cannabis
• A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia
• A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
• Mindfulness-based Social Cognition Training for Psychosis (SocialMind): A Feasibility Study
• The Association Between Epidural Labor Analgesia and Pregnancy Outcomes
• The Norwegian Prednisolone in Early Psychosis Study
• Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
• Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
• Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)
• Efficacy and Safety of Melatonin and Clonazepam for IRBD
• This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
• A Clinical Trial of Intravenous Ganaxolone in Women With Postpartum Depression
• Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release
• Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward
• IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
• "Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
• Levetiracetam in Early Psychosis
• ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
• Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
• Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness
• A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
• Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
• Berberine as Adjuvant Treatment for Schizophrenia Patients
• A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
• Prednisolone Addition for Patients With Recent-onset Psychotic Disorder
• Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
• Clinical Trial for Asses the Safety and Efficacy of Vitamin C and Vitamin E in Combination Versus Placebo for Treating Cognitive and Behavior Disorder in Children With Fragile X Syndrome
• Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
• The Role of Nitric Oxide in Cognition in Schizophrenia
• Tocilizumab in Schizophrenia
• Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
• Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study
• Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
• Striatal Connectivity and Clinical Outcome in Psychosis
• Siltuximab in Schizophrenia
• Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease
• Expanded Access of Pimavanserin for Patients With PD Psychosis
• The Staged Treatment in Early Psychosis Study
• The Sustained Effects of Ketamine
• Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)
• Aspirin in Young Psychotic Patients
• Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
• Cbt for Psychosis and Affect on Psychosis Symptoms
• Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe
• Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
• Antipsychotics and Risk of Hyperglycemic Emergencies
• Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States
• Adult Study Oxytocin - Behavioral
• Gabapentin in Patients at Clinical Risk for Psychosis
• Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
• Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
• Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
• Role Functioning Changes NOS
• A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
• Cannabinoids, Learning, and Memory
• Comparison of Hemodynamics Between Dexmedetomidine and Propofol for Sedation in Patients With Abdominal Surgery
• Fluoxetine vs Aripiprazole Comparative Trial (FACT)
• Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism
• Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
• Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial
• Study of the Effect of Dosing on Clozapine Levels
• Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
• Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
• Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
• Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
• Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
• Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness
• Antipsychotic to Treat Psychosis Syndrome
• Treatment of Psychosis and Agitation in Alzheimer's Disease
• Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia
• Probing the Cannabinoid System in Individuals With a Family History of Psychosis
• Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
• Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis
• Glutamate, Brain Connectivity and Duration of Untreated Psychosis
• Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.
• Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
• A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder
• Vilazodone for Separation Anxiety Disorder
• Simvastatin Addition for Patients With Recent-onset Schizophrenia
• Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
• Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
• A Study of Combination Therapy in Children With ADHD
• Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis
• Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
• Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
• Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults
• Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis
• A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
• Cannabinoids and Cerebellar-Motor Functioning
• Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness
• A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis
• Omega-3 Dietary Supplements in Schizophrenia
• Helping Those With Mental Illness Quit Smoking
• Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
• Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
• A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
• The Role of Antidepressants or Antipsychotics in Preventing Psychosis
• Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis
• Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia
• Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans
• Sequenced Therapies for Comorbid and Primary Insomnias
• Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling
• Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo
• Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.
• Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder)
• Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania
• Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders
• SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
• Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
• DaTSCAN Imaging in Aging and Neurodegenerative Disease
• Bergen Psychosis Project 2 - The Best Intro Study
• NAPLS Omega-3 Fatty Acid Versus Placebo Study
• Sustaining Remission of Psychotic Depression
• Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder
• A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers
• Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
• Special Drug Use Investigation for PAXIL Tablet (Long-term)
• Drug Use Investigation for PAXIL Tablet
• Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
• To Rescue Cognition With Valaciclovir
• Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
• N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis
• The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
• Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
• Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia
• Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
• Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
• Efficacy and Safety of Paliperidone ER in First Episode Psychosis
• Efficacy and Safety With Ziprasidone in First-episode Psychosis
• Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
• Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone
• Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis
• A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder
• Influence of Oxytocin on the Startle Reflex and on Its Modulation
• A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
• Efficacy and Safety of Aripiprazole in First Episode Psychosis
• Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
• Vitamin D Supplementation in Psychiatric Illnesses
• Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry
• Effects of Delta-9-THC and Iomazenil in Healthy Humans
• D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia
• Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
• Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
• Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder
• Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
• Role of Minocycline in First Episode Psychosis
• Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems
• An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)
• Treatment of Psychotic Major Depression With Mifepristone
• Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia
• Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)
• Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
• Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
• A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)
• A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
• Ziprasidone vs Standard Therapy for Agitated Patients in the ED
• Quetiapine in the Treatment of Psychotic Depression - a Pilot Study
• Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
• Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
• Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
• Treatment of Schizoaffective Disorder Using Mifepristone
• Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
• Anticholinergic Burden in Schizophrenia
• Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
• Cannabinoids, Neural Synchrony, and Information Processing
• Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
• Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders
• A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
• A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
• A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
• Ziprasidone in the Psychosis Prodrome
• A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)
• A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis
• First Episode Schizophrenia and Cannabis-Related Disorder Study
• Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects
• Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
• Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)
• A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)
• Iron Supplementation of Marginally Low Birth Weight Infants
• The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
• A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
• Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease
• Early Detection and Intervention for the Prevention of Psychosis
• Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
• Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
• Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
• Repetitive Behavior Disorders in People With Severe Mental Retardation
• ACP-104 in Acutely Psychotic Subjects With Schizophrenia
• Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
• FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
• A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
• RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
• Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder
• Rapid Tranquillization Trial: TREC-India II
• Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.
• Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
• Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
• Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers
• Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis
• Phase III/Seroquel SR Bipolar Depression Monotherapy - US
• Phase 3 /Seroquel SR Acute Mania Monotherapy - US
• Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
• A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment
• Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants
• Antipsychotic Discontinuation in Alzheimer's Disease
• Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
• Study to Compare Two Formulations of Lamotrigine in Healthy Subjects
• Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia
• Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
• Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis
• Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
• Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility Study
• Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
• Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia
• Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia
• Optimizing Response in Psychosis Study
• A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
• Specialized Treatment Early in Psychosis (STEP)
• A Clinical Trial on the Antipsychotic Properties of Cannabidiol
• Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
• Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
• A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
• PET Neuroimaging of [11C]Mirtazapine
• Study of Amantadine for Weight Stabilization During Olanzapine Treatment
• Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
• A Registry of Treatment Adherence for Patients With Schizophrenia
• Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order
• Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)
• Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
• Risperidone LA Heathcare Resource Study
• CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia
• Brain Imaging and Mental Disorders of Aging Intervention
• A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
• Combination Of PAXIL Tablet And Benzodiazepines
• Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache
• Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients
• A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children
• Fast Titration Of Quetiapine Versus Currently Approved Titration
• A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
• A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
• A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
• A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients
• A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia
• A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia
• A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
• A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
• A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
• Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-ac
• A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
• A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
• A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
• Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
• Efficacy of Galantamine to Treat Schizophrenia
• Safety Study of ORG 34517 for Major Depression With Psychotic Features
• Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine
• A Comparative Study of New Medications for Psychosis in Adolescents
• Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults
• A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
• A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease
• A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
• A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)
• A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
• Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids
• Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
• Indicated Prevention of Psychotic Disorders With Low-dose Lithium
• Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication
• Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness
• Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
• V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
• Treatment of Depression With Quetiapine
• Treatment of Major Depressive Disorder With Psychotic Features.
• Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone
• Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms
• Alcoholism and Schizophrenia: Effects of Clozapine
• Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
• Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
• Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
• Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
• An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
• Naltrexone Treatment of Alcohol Abuse in Schizophrenia
• Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study
• Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder
• Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
• A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
• Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
• An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
• A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
• Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease
• The Effects of Risperidone and Olanzapine on Thinking
• Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
• Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
• Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug
• Study of Pharmacotherapy of Psychotic Depression
• The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
• Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
• A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
• CAFE Comparison of Atypicals in First Episode of Psychosis
• A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
• Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease
• Treatment of Behavioral Symptoms in Alzheimer's Disease
• Glycine to Treat Psychotic Disorders in Children
• Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)
• Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections
• Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders
• New Drugs in the Treatment of Mood Disorders
• Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)